Literature & Research

1.

Mesenchymal stem cells and COVID-19: What they do and what they can do.

Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S.

World J Stem Cells. 2021 Sep 26;13(9):1318-1337. doi: 10.4252/wjsc.v13.i9.1318.

2.

Mesenchymal stem cells and their derived exosomes to combat COVID-19.

Yousefi Dehbidi M, Goodarzi N, Azhdari MH, Doroudian M.

Rev Med Virol. 2022 Mar;32(2):e2281. doi: 10.1002/rmv.2281. Epub 2021 Aug 7.

3.

Mesenchymal stem cells and COVID-19: the process of discovery and of translation.

Caplan AI.

Biomater Transl. 2021 Dec 28;2(4):307-311. doi: 10.12336/biomatertransl.2021.04.006. eCollection 2021.

4.

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.

Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N.

Stem Cells Dev. 2020 Jun 15;29(12):747-754. doi: 10.1089/scd.2020.0080. Epub 2020 May 12.

5.

Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.

Huang Y, Li X, Yang L.

Stem Cell Res Ther. 2022 Aug 12;13(1):410. doi: 10.1186/s13287-022-03034-4.

6.

Mesenchymal stem cell therapy for severe COVID-19.

Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS.

Signal Transduct Target Ther. 2021 Sep 8;6(1):339. doi: 10.1038/s41392-021-00754-6.

7.

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.

Verma YK, Verma R, Tyagi N, Behl A, Kumar S, Gangenahalli GU.

Stem Cell Rev Rep. 2021 Feb;17(1):113-131. doi: 10.1007/s12015-020-10037-2.

8.

Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.

Huang Y, Wu Q, Tam PKH.

Int J Mol Sci. 2022 Sep 2;23(17):10023. doi: 10.3390/ijms231710023.

9.

Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.

Xiao K, Hou F, Huang X, Li B, Qian ZR, Xie L.

Stem Cell Res Ther. 2020 Jul 22;11(1):305. doi: 10.1186/s13287-020-01804-6.

10.

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.

Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, Alvarez Gil A, Poggioli R, Ruiz P, Marttos AC, Hirani K, Bell CA, Kusack H, Rafkin L, Baidal D, Pastewski A, Gawri K, Leñero C, Mantero AMA, Metalonis SW, Wang X, Roque L, Masters B, Kenyon NS, Ginzburg E, Xu X, Tan J, Caplan AI, Glassberg MK, Alejandro R, Ricordi C.

Stem Cells Transl Med. 2021 May;10(5):660-673. doi: 10.1002/sctm.20-0472. Epub 2021 Jan 5.

11.

Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends.

Javed A, Karki S, Sami Z, Khan Z, Shree A, Sah BK, Ghosh S, Saxena S.

Biomed Res Int. 2022 Jun 22;2022:9346939. doi: 10.1155/2022/9346939. eCollection 2022.

12.

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial.

Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, Li Y, Xu R, Li TT, Dong J, Cai J, Li G, Xie Y, Shi M, Li Y, Zhang Y, Xie WF, Wang FS.

EBioMedicine. 2022 Jan;75:103789. doi: 10.1016/j.ebiom.2021.103789. Epub 2021 Dec 25.

13.

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.

Gupta A, Kashte S, Gupta M, Rodriguez HC, Gautam SS, Kadam S.

Hum Cell. 2020 Oct;33(4):907-918. doi: 10.1007/s13577-020-00407-w. Epub 2020 Aug 11.

14.

Mesenchymal stem cells in the treatment of COVID-19-progress and challenges.

Wang J, Zou W, Liu J.

Sheng Wu Gong Cheng Xue Bao. 2020 Oct 25;36(10):1970-1978. doi: 10.13345/j.cjb.200216.

15.

Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine.

Hade MD, Suire CN, Suo Z.

Cells. 2021 Aug 1;10(8):1959. doi: 10.3390/cells10081959.

16.

Taming of COVID-19: potential and emerging application of mesenchymal stem cells.

Najafi-Ghalehlou N, Roudkenar MH, Langerodi HZ, Roushandeh AM.

Cytotechnology. 2021 Apr;73(2):253-298. doi: 10.1007/s10616-021-00461-8. Epub 2021 Mar 22.

17.

Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.

Cheng X, Jiang M, Long L, Meng J.

Front Biosci (Landmark Ed). 2021 Oct 30;26(10):948-961. doi: 10.52586/4999.

18.

Stem Cell Therapy in the Treatment of Patients With Autism Spectrum Disorder: a Systematic Review and Meta-analysis.

Villarreal-Martínez L, González-Martínez G, Sáenz-Flores M, Bautista-Gómez AJ, González-Martínez A, Ortiz-Castillo M, Robles-Sáenz DA, Garza-López E.

Stem Cell Rev Rep. 2022 Jan;18(1):155-164. doi: 10.1007/s12015-021-10257-0. Epub 2021 Sep 13.

19.

Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.

Nestor MW, Phillips AW, Artimovich E, Nestor JE, Hussman JP, Blatt GJ.

Autism Res. 2016 May;9(5):513-35. doi: 10.1002/aur.1570. Epub 2015 Oct 1.

20.

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels.

Riordan NH, Hincapié ML, Morales I, Fernández G, Allen N, Leu C, Madrigal M, Paz Rodríguez J, Novarro N.

Stem Cells Transl Med. 2019 Oct;8(10):1008-1016. doi: 10.1002/sctm.19-0010. Epub 2019 Jun 11.

21.

The use of stem cells to study autism spectrum disorder.

Ardhanareeswaran K, Coppola G, Vaccarino F.

Yale J Biol Med. 2015 Mar 4;88(1):5-16. eCollection 2015 Mar.

22.

Stem Cell-Derived Exosomes in Autism Spectrum Disorder.

Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D.

Int J Environ Res Public Health. 2020 Feb 4;17(3):944. doi: 10.3390/ijerph17030944.

23.

Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises.

Simberlund J, Ferretti CJ, Hollander E.

World J Biol Psychiatry. 2015 Sep;16(6):368-375. doi: 10.3109/15622975.2015.1067372. Epub 2015 Jul 31.

24.

Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.

Vitrac A, Cloëz-Tayarani I.

Stem Cell Res Ther. 2018 Aug 23;9(1):226. doi: 10.1186/s13287-018-0966-2.

25.

Stem Cells for Improving the Treatment of Neurodevelopmental Disorders.

Donegan JJ, Lodge DJ.

Stem Cells Dev. 2020 Sep 1;29(17):1118-1130. doi: 10.1089/scd.2019.0265. Epub 2020 Mar 5.

26.

Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model.

Ha S, Park H, Mahmood U, Ra JC, Suh YH, Chang KA.

Behav Brain Res. 2017 Jan 15;317:479-484. doi: 10.1016/j.bbr.2016.10.004. Epub 2016 Oct 4.

Start typing and press enter to search

Scroll to Top
Icon
close